Tokyo, Japan--(Newsfile Corp. - October 1, 2023) - Elsevier, a global leader in scientific information and data analytics, today announces the successful delivery of a solution on the e-CSTI platform through a collaboration with The Cabinet Office (CAO), Government of Japan, for robust decision-making on Japan's research-related policies founded on evidence-based information and data.
e-CSTI is a portal developed by CAO and launched in 2020 to promote and strengthen evidence-based decision- and policymaking in funding scientific and technological research as part of Japan's Fifth Basic Science and Technology Plan. The platform is continuously enhancing and upgrading its analytic scope and capability in response to the evolving needs of Japan's scientific and research priorities.
Accessible to policy makers, research funders, university leaders and the public, e-CSTI analyzes the relationship between research input and output to assess the outcome and impact resulting from investments into researcher and university activities.
By integrating bibliometrics data from Scopus, the world's leading abstract and citation database of peer-reviewed literature with journal records from J-STAGE, an online journal platform for Japanese learned societies developed and managed by the Japan Science and Technology Agency, Elsevier is able to deliver a more comprehensive, objective and accurate view of researcher profiles over the e-CSTI platform.
Naoaki Kashiwabara, Director of Cabinet Office, Japan, said: "The integration of Scopus and J-STAGE databases is a landmark development for e-CSTI, which has been in operation for three years. We believe that the upgraded database will make significant contribution by providing essential inputs for evidence-based policy making and corporate management to Japan's science, technology and innovation communities."
M'hamed Aisati, Vice President of Analytical and Data Services, said: "We are thrilled to extend our collaboration with CAO. Japan stands at the forefront of evidence-based decision-making, thanks to its e-CSTI platform. As a global leader in digital information solutions, we are poised to bolster CAO's efforts in shaping strategic priorities, guiding investment decisions, and shaping the landscape of research development policies."
The solution involved the integration of 1.4 million records that generated about 0.8 million new researcher profiles, enriched 1 million existing profiles and created 9 million new citation links.
The enhanced e-CSTI platform delivers the following capabilities and benefits to key stakeholders engaged in the Japanese research ecosystem:
-
Provide government ministries, university leaders and administrators as well as research funders with insights into the impact of university research and the contribution from each unique stakeholder.
-
Analyze how the underpinning components are contributing to the research ecosystem, i.e., the contribution arising from inputs into research (e.g., funding), the outputs of research (e.g., research papers, patents); as well as providing an understanding as to how these components can be optimally managed.
-
Provide stronger evidence regarding the research ecosystem, thereby enabling a more effective and transparent process for improved policymaking. For example, using more comprehensive information to support the allocation of funding to future research activities.
--
About e-CSTI
Raising the research, educational, and fundraising capabilities of universities and other research institutes is extremely important to improving Japan's science and technology capabilities. Thus, the Council for Science, Technology and Innovation (CSTI) has collected and analyzed evidence on the status of research, education, and fundraising at universities and other research institutes. e-CSTI (an evidence data platform) was then constructed as a means of sharing this evidence with relevant parties at the governmental, university, and research institute levels. It is expected that such parties will utilize e-CSTI data to pursue evidence-based policy making (EBPM) and evidence-based corporate management (EBMgt).
About Elsevier
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, academic leaders, funders, R&D-intensive corporations, doctors, and nurses.
Elsevier employs 9,000 people worldwide, including over 2,500 technologists. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on over 2,800 journals, including The Lancet and Cell; 46,000+ eBook titles; and iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.
Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.
Media contact
Jason Chan
+65 6349 0240
[email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/182210